Concepedia

Eli Lilly (Singapore)

EL

Statistics

Publications

423

Citations

94.7K

Authors

15

Location

Singapore, Singapore

Eli Lilly (Singapore) is a company institution in Singapore, Singapore known for medicine, life sciences, and pharmacology.

HomepageROR

Top concepts

Publications

423

Donanemab in Early Alzheimer’s Disease

Mark A. Mintun, Albert Lo, Cynthia Evans et al. · New England Journal of Medicine · 2021 · 1.7K citations · Full text

, , +17

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

, , +14

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

Rachelle S. Doody, Rema Raman, Martin R. Farlow et al. · New England Journal of Medicine · 2013 · 1.2K citations

, , +17

Risk of Advanced Proximal Neoplasms in Asymptomatic Adults According to the Distal Colorectal Findings

Thomas F. Imperiale, David R. Wagner, Ching Y. Lin et al. · New England Journal of Medicine · 2000 · 1.1K citations · Full text

, , +17

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

Lawrence S. Honig, Bruno Vellas, Merçé Boada et al. · New England Journal of Medicine · 2018 · 1K citations · Full text

, , +17

1–5 of 423

Authors

15

  1. SW
    Susan Warner

    Eli Lilly (Singapore), Singapore

    14 publications · 879 citations

    11

    h-index

  2. AH
    Anne Hawdon

    Eli Lilly (Singapore), Singapore

    4 publications · 407 citations

    4

    h-index

  3. DB
    Donnelly B Kevin

    Eli Lilly (Singapore), Singapore

    3 publications · 38 citations

    3

    h-index

  4. CT
    Colleen Terrell

    Eli Lilly (Singapore), Singapore

    3 publications · 413 citations

    2

    h-index

  5. TW
    Theresa Womack

    Eli Lilly (Singapore), Singapore

    1 publications · 174 citations

    1

    h-index

1–5 of 15